(2026). Real-world clinical effectiveness of trimethoprim–sulfamethoxazole for primary prophylaxis of pneumocystis pneumonia in non-hodgkin lymphoma patients treated with rituximab. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Real-world Clinical Effectiveness of Trimethoprim–sulfamethoxazole for Primary Prophylaxis of Pneumocystis Pneumonia in Non-hodgkin Lymphoma Patients Treated with Rituximab."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Real-world Clinical Effectiveness of Trimethoprim–sulfamethoxazole for Primary Prophylaxis of Pneumocystis Pneumonia in Non-hodgkin Lymphoma Patients Treated with Rituximab."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.